Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Amniotic Fluid for COVID-19 Associated Respiratory Failure
NCT04319731Phase 1Completed
- Sponsor
- University of Utah
- Start
- Mar 2020
- Primary completion
- Jun 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of processed amniotic fluid in coronavirus disease 2019 (COVID-19), sponsored by University of Utah. Primary endpoints: Ventilator Free Days at 60 days and Duration of supplemental oxygen use at 60 days. Started Mar 2020; status: completed.
02
Drugs
processed amniotic fluid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04319731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319731.